Sunday, October 12, 2025

Latest

The Deep Dive Compiles Company Profile on Khiron Life Sciences

The Deep Dive has assembled a company profile for that of Khiron Life Sciences (TSXV: KHRN), a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe.

Khiron currently has distribution throughout various countries in Latin America, along with activity in North America and Europe. The company is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products from Colombia to UK, Peru and Uruguay/Brazil.

The overall thesis from our view can be broken into the following key points:

  1. Khiron is the early leader in Colombia with a fully vertical operation and regulatory ability and permits to export products internationally.
  2. Khiron stands out from their Latin American publicly traded competitors in terms of both revenue and balance sheet strength.
  3. They are the first to market with CBD cosmetic products in Colombia under the KUIDA brand.
  4. Khiron is one of a handful of suppliers producing medical cannabis products for distribution in the United Kingdom through Project Twenty21.
  5. The company has a balance sheet that gives them the strength to be careful and diligent within their growth strategy. More importantly, the balance sheet strength reduces shareholders dilution risk relative to vast majority of other cannabis companies.

Overall we feel Khiron is the leading distribution and service oriented company in a country that can offer the lowest cost cannabis products in the world and a huge base of patients. They have a prudent strategy to grab distribution in countries moving towards legalization and already have a proven suite of products available to plug into each new channel at industry leading costs of production.


FULL DISCLOSURE: Khiron Life Sciences is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Khiron Life Sciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

First Majestic Posts Record Quarterly Silver Production In Q3

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

Related News

Khiron Life “Renews” Buyback Program, Last Program Was A Bust

Khiron Life Sciences (TSXV: KHRN) this morning announced that it is renewing its normal course...

Tuesday, September 14, 2021, 08:19:09 AM

Khiron Life Sciences Announces German Cannabis Distribution Deal

Khiron Life Sciences (TSXV: KHRN) has signed a German distribution deal with that of Nimbus...

Thursday, June 25, 2020, 10:42:43 AM

Harvest Moon: Khiron Life Sciences Posts Encouraging Earnings

Overall, we view the recent announcements and earnings surrounding Khiron Life Sciences (TSXV: KHRN) as...

Tuesday, May 5, 2020, 08:50:19 AM

Khiron Launches Kuida CBD Skincare Products Into Hong Kong Market

Khiron Life Sciences (TSXV: KHRN) is going to Asia. The company announced this morning that...

Monday, August 10, 2020, 09:13:10 AM

Khiron Life Sciences Receives Authorization For The Sale Of High-CBD Medical Cannabis In Peru

Khiron Life Sciences (TSXV: KHRN) announced this morning that it now has access to yet...

Thursday, July 23, 2020, 08:59:43 AM